Related Experiment Video
Updated: Jul 6, 2026
08:30
Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
Published on: March 12, 2016
Initial clinical experience with the trabecular micro-bypass stent in patients with glaucoma
Detlev Spiegel1, Wolfgang Wetzel, David S Haffner
1Klinik Vincentinum, Ausburg, Germany.
Advances in Therapy
|May 29, 2007
Summary
A new micro-bypass stent effectively lowers intraocular pressure (IOP) and reduces medication needs in glaucoma patients. This minimally invasive procedure showed promising safety and efficacy in a small feasibility study.
Area of Science:
- Ophthalmology
- Medical Devices
- Glaucoma Research
Background:
- Glaucoma management often requires medication and can involve invasive surgeries.
- Trabecular bypass surgery offers a less invasive alternative for aqueous humor drainage.
- Evaluating novel micro-stent devices is crucial for advancing glaucoma treatment.
Purpose of the Study:
- To assess the efficacy and safety of a trabecular micro-bypass stent for glaucoma.
- To evaluate the stent's ability to facilitate direct aqueous drainage.
- To determine the impact on intraocular pressure (IOP) and medication requirements.
Main Methods:
- Prospective case series of 6 open-angle glaucoma patients.
- Ab interno implantation of a trabecular micro-bypass stent under local anesthesia.
- Postoperative follow-up at multiple intervals up to 12 months.
Main Results:
- Successful stent placement in Schlemm's canal in all patients.
- Significant reduction in mean IOP from 20.2 mmHg preoperatively to 14-15 mmHg at 12 months.
- Reduced need for glaucoma medications throughout the follow-up period.
- No major complications reported; stents remained in place.
Conclusions:
- The trabecular micro-bypass stent is effective in reducing IOP and medication burden in glaucoma patients.
- The implantation procedure demonstrated safety and feasibility.
- Further research with larger patient cohorts is warranted to confirm these findings.
Related Concept Videos
01:25Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...